As of Feb 24
| -0.01 / -1.92%|
The 1 analysts offering 12-month price forecasts for Tonix Pharmaceuticals Holding Corp have a median target of 0.60, with a high estimate of 0.60 and a low estimate of 0.60. The median estimate represents a +17.65% increase from the last price of 0.51.
The current consensus among 1 polled investment analysts is to Hold stock in Tonix Pharmaceuticals Holding Corp. This rating has held steady since February, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.